US Map / Ohio
State OH

Clinical Trials in Ohio

Ohio is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Ohio and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 475 actively recruiting studies with Ohio sites out of 475 registered in total. The busiest research areas in Ohio are Ovarian Cancer, Solid Tumor, Advanced Solid Tumor. Leading sponsors running trials in the state include Children's Hospital Medical Center, Cincinnati, The Cleveland Clinic, National Cancer Institute (NCI). By stage, Ohio trials break down as Phase 1 (96), Phase 2 (140), Phase 3 (106), Phase 4 (16).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
475
Recruiting Now
475
← Back to US Map
Top Conditions in Ohio
Ovarian Cancer (9)Solid Tumor (8)Advanced Solid Tumor (8)Heart Failure (7)Colorectal Cancer (7)Prostate Cancer (7)Schizophrenia (7)Acute Myeloid Leukemia (6)Advanced Solid Tumors (6)Chronic Lymphocytic Leukemia (6)Multiple Myeloma (5)Metastatic Castration-resistant Prostate Cancer (5)

Frequently Asked Questions — Clinical Trials in Ohio

How many clinical trials are currently recruiting in Ohio?
ClinicalMetric currently tracks 475 actively recruiting clinical trials with at least one location in Ohio. The total number of registered studies—including active but not currently enrolling trials—is 475. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Ohio?
Ohio hosts clinical trials across a broad range of medical conditions, including Ovarian Cancer, Solid Tumor, Advanced Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Ohio serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Ohio?
To join a clinical trial in Ohio, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Ohio maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Ohio

NCT06078683 N/A
Recruiting
Effects of Ketone Ester Consumption on Exercise Tolerance and Cardiac Function
Condition
Type 2 Diabetes
Enrollment
30 pts
Location
United States
Sponsor
Ohio State University
View Trial →
NCT04300556 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein ...
Condition
Solid Tumor
Enrollment
182 pts
Location
United States, France, Japan
Sponsor
Eisai Inc.
View Trial →
NCT03355456 N/A
Recruiting
Low Voltage-Directed Catheter Ablation for Atrial Fibrillation
Condition
Atrial Fibrillation - Symptomatic
Enrollment
250 pts
Location
United States
Sponsor
Ohad Ziv
View Trial →
NCT03686124 Phase 1, Phase 2
Recruiting
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in R...
Condition
Refractory Cancer
Enrollment
375 pts
Location
United States, Germany
Sponsor
Immatics US, Inc.
View Trial →
NCT06563596 Phase 2
Recruiting
Epco, Zanu, Ritux for R/R FL or MZL
Condition
Follicular Lymphoma
Enrollment
71 pts
Location
United States
Sponsor
Reid Merryman, MD
View Trial →
NCT07519096 N/A
Recruiting
Steady Together Fall Prevention Program in the Home
Condition
PARKINSON DISEASE (Disorder)
Enrollment
50 pts
Location
United States
Sponsor
Cleveland State University
View Trial →
NCT06994806 Phase 1
Recruiting
A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in C...
Condition
Solid Tumor Malignancies
Enrollment
84 pts
Location
United States
Sponsor
Kumquat Biosciences Inc.
View Trial →
NCT03541889 Phase 1
Recruiting
REVEAL Biomarkers of Engraftment After Alternative Donor HSCT
Condition
Primary Graft Failure
Enrollment
50 pts
Location
United States
Sponsor
University of Oklahoma
View Trial →
NCT07015697 Phase 1
Recruiting
A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic S...
Condition
Recurrent or Metastatic Solid Tumors
Enrollment
76 pts
Location
United States, Brazil, France
Sponsor
Daiichi Sankyo
View Trial →
NCT05761223 Phase 1, Phase 2
Recruiting
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and ...
Condition
Advanced Solid Tumor
Enrollment
151 pts
Location
United States
Sponsor
1ST Biotherapeutics, Inc.
View Trial →
NCT05803343 N/A
Recruiting
Evaluating Additive Effects of Including Canines in Regulating Together
Condition
Autism Spectrum Disorder
Enrollment
240 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
View Trial →
NCT07681596 Phase 1, Phase 2
Recruiting
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants Wi...
Condition
Relapsed or Refractory Multiple Myeloma
Enrollment
101 pts
Location
United States, Australia
Sponsor
AstraZeneca
View Trial →
NCT07277946 N/A
Recruiting
AtraUmatic Laparoscopic HerNia Repair Clinical Investigation to Evaluate the Saf...
Condition
Hernia
Enrollment
240 pts
Location
United States
Sponsor
Tissium
View Trial →
NCT05142189 Phase 1
Recruiting
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of B...
Condition
Non-Small Cell Lung Cancer
Enrollment
320 pts
Location
United States, Australia, Germany
Sponsor
BioNTech SE
View Trial →
NCT06765668 Phase 4
Recruiting
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Partici...
Condition
Parkinson Disease
Enrollment
220 pts
Location
United States
Sponsor
Impax Laboratories, LLC
View Trial →
NCT06976268 Phase 2, Phase 3
Recruiting
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment...
Condition
Parkinson Disease
Enrollment
550 pts
Location
United States
Sponsor
Biohaven Therapeutics Ltd.
View Trial →
NCT07593391 Phase 3
Recruiting
An Open-label Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid S...
Condition
Phelan-McDermid Syndrome
Enrollment
180 pts
Location
United States
Sponsor
Neuren Pharmaceuticals Limited
View Trial →
NCT07114874 Phase 3
Recruiting
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizoph...
Condition
Schizophrenia
Enrollment
600 pts
Location
United States, Bulgaria, Puerto Rico
Sponsor
Neurocrine Biosciences
View Trial →
NCT03850574 Phase 1, Phase 2
Recruiting
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharma...
Condition
Leukemia, Myeloid, Acute
Enrollment
240 pts
Location
United States, Australia, Germany
Sponsor
Aptose Biosciences Inc.
View Trial →
NCT07219420 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants...
Condition
Palmoplantar Pustulosis
Enrollment
320 pts
Location
United States, Canada, China
Sponsor
UCB Biopharma SRL
View Trial →
NCT06608823 N/A
Recruiting
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
Condition
Aortic Regurgitation
Enrollment
1,016 pts
Location
United States
Sponsor
JenaValve Technology, Inc.
View Trial →
NCT07227246 Phase 3
Recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Condition
Intracerebral Hemorrhage
Enrollment
350 pts
Location
United States, Canada, Germany
Sponsor
Joseph Broderick, MD
View Trial →
NCT05626114 Phase 2
Recruiting
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Acti...
Condition
Geographic Atrophy
Enrollment
60 pts
Location
United States, Israel
Sponsor
Genentech, Inc.
View Trial →
NCT04363684 N/A
Recruiting
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
Condition
Frontotemporal Lobar Degeneration (FTLD)
Enrollment
2,100 pts
Location
United States, Canada
Sponsor
Mayo Clinic
View Trial →
NCT06562543 Phase 4
Recruiting
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populati...
Condition
Colorectal Cancer
Enrollment
78 pts
Location
United States, Puerto Rico
Sponsor
Takeda
View Trial →
Page 8 of 19 — 475 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology